by Annie De Groot | Apr 16, 2013 | News
Providence Business News Article: life sciences EpiVax, partners move ahead on H7N9 flu vaccine production COURTESY UNIVERSITY OF RHODE ISLAND EPIVAX, the life sciences company founded by Dr. Anne S. De Groot, is engaged in pioneering efforts with Aldevron, a life...
by Annie De Groot | Apr 12, 2013 | News, Thinking Out Loud -Blog
Is H7N9 influenza a ‘Stealth’ virus? What we found: The bioinformatics team at EpiVax examined H7N9 (Shanghai 2013) sequence and found an unusually low number of T cell epitopes (see figure below). We predict that it will be difficult to make...
by Annie De Groot | Apr 20, 2012 | News
Mark Poznansky, MD, PhD, turns on the computer in his office within the MGH’s Vaccine Immunotherapy Center (VIC) at the Charlestown Navy Yard. Within moments, his team is connected via international teleconferencing to four other academic and biotech company...
by Annie De Groot | Nov 27, 2011 | News
Treatment as Prevention – the new vaccine for AIDS? Julio Montaner, Myron Cohen and Jon Cohen, are Hope is a Vaccine Award Winners, 2011 Access to treatment is the main reason that AIDS-related deaths have tumbled in recent years. That’s something 2011 Hope Is a...
by Annie De Groot | Nov 12, 2010 | Thinking Out Loud -Blog
This post is by John Rozehnal and Lauren Levitz – Volunteers HIV vaccine research at the GAIA Vaccine Foundation project in Mali, West Africa. Lauren works at EpiVax, John R. works at the Institute for immunology and Informatics and both are recent graduates from...
